Introduction
Idiopathic or cyclical oedema is a disorder almost exclusively of women, characterised by intermittent bouts of generalised swelling aggravated by standing. Other recognised causes of oedema must first be excluded, and the diagnosis then rests on the typical symptom complex and whether an excessive diurnal weight gain occurs.'-3 The cause of the condition is uncertain. Previous studies have suggested that women with cyclical oedema have chronic hypovolaemia and that standing induces a decrease in urine flow and urinary excretion of sodium,' 4 5 but the mechanism for this hypovolaemia is disputed.
Attention has been drawn to the emotional lability exhibited by women with cyclical oedema.' 6-8 So prominent is this feature that Thorn suggested that it should form a part of the clinical symptom complex for establishing the diagnosis.3 The major depressive disorders are often associated with a disturbance of the hypothalamic-pituitary axis,9-2 and in view of the psychological and emotional problems that accompany cyclical oedema we carried out a study to investigate hypothalamic function by means of a combined thyrotrophin releasing hormone and luteinising hormone releasing hormone test in 14 women with the disorder.
Subjects and methods
Women complaining of generalised swelling and with a documented diurnal weight gain in excess of 14 kg were considered to have cyclical oedema provided that other causes of oedema had been excluded by physical examination and biochemical investigation. We studied 14 patients (mean age 35±SEM 30 years and mean weight 67 ±3-5 kg) and six normal female volunteers (mean age 32±2-5 years and mean weight 61 5±2-0 kg). No subject in either group was taking an oral contraceptive pill, but most patients had previously received diuretics. Whenever possible diuretic treatment was slowly withdrawn so that at the time of the study eight patients had stopped taking diuretics a minimum of three months previously, three were receiving them, and three had never received them. Informed consent was obtained, and the study was approved by the hospital research ethics committee.
All subjects were studied during the preovulatory phase of the menstrual cycle as confirmed by plasma oestradiol and progesterone concentrations. The study was conducted by the same investigator with the subjects recumbent after an overnight stay in hospital. A light standard breakfast was given at 0800 and an intravenous cannula inserted at 0900. At 1000 basal blood samples were taken for measure subclinical hypothyroidism may present with features similar to those of cyclical oedema, and it is important to identify these patients as they may respond to treatment with thyroxine20 or triiodothyronine (W J Jeffcoate and R J E Davis, personal communication). Our patients had normal serum thyroxine and triiodothyronine concentrations and a normal free thyroxine index, but in two cases an exaggerated response of thyroid stimulating hormone was observed, suggesting subclinical hypothyroidism. One of these patients was treated with 200 FLg thyroxine daily for two months. Her pitting oedema did not improve, and a further test using thyrotrophin releasing hormone and luteinising releasing hormone showed suppression of thyroid stimulating hormone, but prolactin and luteinising hormone responses remained abnormal. An exaggerated response of luteinising hormone due to a proposed primary hypothalamic abnormality has also been found in the polycystic ovarian syndrome,5' some clinical features of which (obesity and oligomenorrhoea) may overlap with those of cyclical oedema. Some of our patients were obese and others had oligomenorrhoea, but there were no other features to suggest the polycystic ovarian syndrome, and plasma testosterone concentrations were normal in all patients.
If a hypothalamic disturbance does exist in cyclical oedema then there must be a link between this central defect and a peripheral mechanism for the formation of oedema. We found an abnormality in prolactin regulation, and prolactin has been shown to cause isotonic movement of water from the intracellular to the extracellular fluid compartments22; this might explain some of the peripheral features of cyclical oedema. Basal prolactin concentrations were abnormal in two previously reported cases of cyclical oedema.'9 23 In both cases hyperprolactinaemia was present, associated in one case with galactorrhoea and amenorrhoea23; and both patients became free of oedema in response to treatment with bromocriptine, a dopamine agonist that inhibits secretion of prolactin. Oedema is not, however, a feature of hyperprolactinaemia associated with prolactinomas and cannot therefore be solely due to excessive secretion of prolactin. The oedema might be explained by a more generalised hypothalamic disturbance including an abnormality in the release of natriuretic factor. This would be in keeping with previous observations suggesting altered secretion of natriuretic factor in cyclical oedema.24
The abnormalities of secretion of prolactin, follicle stimulating hormone, and luteinising hormone that we found support the concept that cyclical oedema is due to a generalised hypothalamic disturbance producing the somatic and psychological features of the condition. Alternatively, there may be an undefined peripheral factor with secondary hormonal changes that are only markers for the condition. Once an abnormality in the hypothalamic-pituitary axis has been identified the effect of diuretics, dopamine agonists, and centrally acting antidepressant drugs on this abnormality should be determined in the hope that a more effective treatment may be developed.
In addition, the test using thyrotrophin releasing hormone and luteinising hormone releasing hormone may enable a more precise and objective diagnosis to be made in this common and distressing disorder.
We There have, however, been no observations on pancreatic lipase activity in sera of these patients. We therefore undertook a study to examine whether the activity of this enzyme is altered in cystic fibrosis.
Patients and methods
Blood samples were collected from 23 patients with known cystic fibrosis (age range 12 to 38 years) with sweat sodium and chloride concentrations greater than 70 mmol(mEq)/l. The serum was separated and stored at -20°C.
Serum was thawed on the day of the assay, and the assays for immunoreactive trypsin and pancreatic lipase were undertaken on
